Trial Profile
A Study to Investigate the Effects of JNJ-38518168 on Methotrexate Pharmacokinetics in Rheumatoid Arthritis Participants on a Stable Methotrexate Dose.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 May 2013
Price :
$35
*
At a glance
- Drugs Toreforant (Primary) ; Methotrexate
- Indications Rheumatic disorders
- Focus Pharmacokinetics
- 23 Dec 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 23 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Dec 2011 Actual patients number (20) added as reported by ClinicalTrials.gov.